Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?

Eur J Heart Fail. 2010 Dec;12(12):1297-9. doi: 10.1093/eurjhf/hfq175. Epub 2010 Oct 16.

Authors

Maarten P van den Berg¹, Karin Y van Spaendonck-Zwarts, Dirk J van Veldhuisen, Jourik A Gietema, Aleida Postma, J Peter van Tintelen

Affiliation

¹ Department of Cardiology, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands. [email protected]

PMID: 20952769
DOI: 10.1093/eurjhf/hfq175

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anthracyclines / adverse effects
Antibiotics, Antineoplastic / adverse effects*
Cardiomyopathy, Dilated / chemically induced
Cardiomyopathy, Dilated / genetics
Cardiotoxins
Daunorubicin / adverse effects*
Doxorubicin / adverse effects*
Genetic Predisposition to Disease
Humans
Male
Neoplasms / drug therapy
Risk Factors
Ventricular Dysfunction, Left / chemically induced*
Ventricular Dysfunction, Left / genetics
Ventricular Function, Left / drug effects

Substances

Anthracyclines
Antibiotics, Antineoplastic
Cardiotoxins
Doxorubicin
Daunorubicin

Supplementary concepts

Familial dilated cardiomyopathy